Lineage Cell Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lineage Cell Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.58M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.58M Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.86M Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.52M Dec 31, 2023 10-Q 2024-08-08
Q4 2020 $215K -$560K -72.3% Dec 31, 2020 10-K 2021-03-11
Q4 2019 $775K Dec 31, 2019 10-K 2021-03-11
Q3 2019 $4.95M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.55M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $4.68M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.